$NTSK

ICONIQ Strategic Partners VIII Holdings, L.P. purchased $7.2M of NTSK

ICONIQ Strategic Partners VIII Holdings, L.P. purchased 610,291 shares of Netskope Inc (NTSK) at an average of $11.82 ($11.66–$11.82, $7.22M total) across 2 trades on 2026-07-08.

Original reporting
SEC EDGAR · ICONIQ Strategic Partners VIII Holdings, L.P.
Published Jul 10, 2026, 11:39 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jul 10, 2026, 11:43 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$NTSK
Bullish
medium confidence
Mentioned
$NTSK
Relevance
7/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$NTSKBullishLow
01

Why it matters

The transaction adds incremental ownership exposure for the reporting holder but does not include new company performance metrics or forward guidance.

02

Market read

Traders may treat the purchase as a mild sentiment input, but it is unlikely to drive a fundamental repricing without additional catalysts.

03

What to watch

The filing does not disclose intent, horizon, or whether the buyer has other concurrent positions; without follow-on disclosures, signal strength is modest.

Relevance 7/10Novelty 5/10Timing: Filed on 2026-07-10 for a purchase dated 2026-07-08.

Background

This is an SEC Form 4 insider transaction disclosure for Netskope, reported by a 10% owner.

Company-level read

Ticker impact

$NTSKBullishMedium confidence
Context

Netskope (NTSK) disclosed via Form 4 that ICONIQ Strategic Partners VIII Holdings, L.P. bought 610,291 shares for about $7.22M.

Expected impact

Near-term impact likely limited; any effect would be sentiment-driven rather than a new operating catalyst.

Evidence & confidence

The filing is a primary-source insider transaction, but it provides no new guidance, contract, or operational update, and it is not a 10b5-1 plan.

Market effects

Limited read-across to cloud security peers because the disclosure is company-specific and lacks new sector data.

No clear regional linkage beyond US-listed insider activity.

Minimal global relevance; no international transaction or regulatory action described.

Counterpoint

Open-market purchases can reflect liquidity management or portfolio rebalancing rather than a forward-looking view on fundamentals.

Key entities

  • Netskope Inc

    Subject of the Form 4 insider transaction disclosure.

  • ICONIQ Strategic Partners VIII Holdings, L.P.

    Reporting party that purchased 610,291 shares in open-market trades.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$NTSKMed

Why Netskope Stock Crushed it This Week

Netskope (NTSK) shares rose 19% this week, benefiting from improved cybersecurity sentiment and a buy rating from Stephens with a $21 price target. The surge followed AI safety concerns raised by industry leaders, driving demand for cybersecurity stocks.

$NTSKHighAI 8/10

Netskope’s (NTSK) AI Security Push Is Already Paying Off

Netskope (NTSK) reported Q2 revenue of $220.5M, up 27% YoY, and raised its full-year outlook. AI security initiatives are driving growth, with 33% of its pipeline in or entering the proof-of-concept phase. However, the company posted negative free cash flow of $29.8M and expects a full-year free cash flow margin of about 2%.

$NTSKHighAI 8/10

Netskope (NTSK) Q2 2027 Earnings Call Transcript

Netskope (NTSK) reported Q2 2027 earnings with ARR of $899M (27% growth), revenue of $220.5M (29% growth), and raised full-year revenue guidance to $888M-$892M. Key metrics include 114% net retention rate, 1,686 large customers, and 59% platform adoption. Management highlighted AI security opportunities and risks, including faster transition to annual billings.

$NTSKMedAI 8/10

Netskope (NTSK) Stock Rises As ARR Growth Outruns Profit Progress

Netskope (NTSK) stock rose 4.3% to $14.34 after reporting Q2 2027 revenue of $220.5m (up 29% YoY) and ARR of $899m (up 27% YoY). Net loss widened 23% to $110.8m, but adjusted operating margin improved to a 9% loss. Management targets positive free cash flow in Q3. Analysts debate whether growth justifies valuation.

$NTSKMed

BMO raises Netskope stock price target on ARR growth outlook

BMO Capital increased its price target for Netskope (NTSK) to $18.00 from $13.00, citing strong ARR growth and improved performance. The stock, trading at $14.29, has a 26% upside potential. Netskope reported Q2 earnings beating estimates, with revenue of $221M and raised its full-year outlook. Multiple analysts raised their price targets following the results.